P27.1 P52 P36.9 P39.9 P77 P91.1 H35.1 P23.9 P28.5 G80 G00
Conditions
Interventions
Group 1: Preterm infants born < 29 weeks of gestation with Ureaplasma colonisation and/or infection
Group 2: Preterm infants born < 29 weeks of gestation without Ureaplasma colonisation and/or infecti
Sponsors
Universitätsklinikum Würzburg, Kinderklinik und Poliklinik
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inborn patient Written parental consent
Exclusion criteria
Exclusion criteria: Severe or letal malformations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk of development of bronchopulmonary dysplasie at 36 weeks or combined outcome BPD / death before 36 weeks of gestation | — |
Secondary
| Measure | Time frame |
|---|---|
| (a) Risk of perinatal inflammation with elevated cord blood cytokines / chemokines and persistance for 4 weeks postnatally (b) Risk of complications (infection, sepsis, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathia praematurorum) (c) Risk of developmental retardation at the corrected age of 24 months | — |
Countries
Austria, Germany
Contacts
Public ContactChristine Silwedel
Universitätsklinikum Würzburg, Kinderklinik und Poliklinik
Outcome results
None listed